Professional Documents
Culture Documents
Reference article:
Article title:
Global Vitamin C Status and Prevalence of Deficiency: A Cause for Concern?
Reference:
Carr, A.C. & Rowe, S. (2020). Global Vitamin C Status and Prevalence of Deficiency: A Cause for Concern?.
Retrieved from: https://doi.org/10.3390/nu120720088
Why is it important?
Vitamin C is an essential nutrient that must be obtained through the diet in adequate amounts to prevent
hypovitaminosis C, deficiency and its consequences. This includes the potentially fatal deficiency disease known as
scurvy.
However, in spite of vitamin C's pleiotropic functions in both communicable and non-communicable disease, the
global status and prevalence of vitamin C deficiency have not yet been recorded. This makes the article all the more
significant.
50 µmol/L, which is an adequate amount (>50 µmol/L) and 9,117 assessed individuals from LMIC (low- and middle-
income countries), suggest a mean vitamin C status of approximately 24 µmol/L, which is at the tipping point for
hypovitaminosis C (<23 µmol/L). Despite the mean value of the vitamin C levels of HIC being adequate, about 18% of
the assessed individuals are reported to have Hypovitaminosis C and about 5% to be vitamin C deficient, still quite a
number of people.
First, methodological issues in the handling and analysis of vitamin C status may be problematic in LMIC due to
lack of adequate infrastructure and resources, particularly in rural settings, which could result in falsely low levels and as
such should be interpreted with some caution.
Intakes (of vitamin C) are also frequently calculated by nutritional tables that rarely factor in the effects of
storage, processing and cooking on vitamins, which contribute to overestimation of intakes.
A further issue is consensus on the cutoffs for inadequacy; vitamin C deficiency is usually defined as plasma
concentrations <11 µmol/L, however, although hypovitaminosis C is often defined as <23 µmol/L, some studies report
‘inadequacy’ as <28 µmol/L (or even <30 or 34 µmol/L), therefore making it difficult to directly compare prevalence
between studies.
Finally, only a small percentage of the world’s countries have been represented, most of which were high- and
upper middle-income countries. This is of concern since there are clearly significant issues with vitamin C status and
prevalence of deficiency in LMIC.
What are the main conclusions and implications in the wider context?
In light of the aforementioned limitations, this study suggests that vitamin C deficiency is likely to be widespread
worldwide—and in low-income groups and low-middle income countries in particular. Despite this, many nations and
populations' vitamin C status has not yet been evaluated. Therefore, additional study is needed to investigate this in
various areas of the world.
Given the growing burden of non-communicable disease in low- and middle-income settings and multiple
infectious diseases showing up everywhere, increasing vitamin C intake could be a low-cost and successful public health
measure in these locations.
Interventions to help optimize vitamin C nutriture worldwide could include: education, increased dietary
recommendations (e.g., by the WHO), reduced tax on fresh fruit and vegetables, encouraging local growing of fruit and
vegetables in LMICs, novel vitamin C tax reductions for products such as soft drinks that are high in vitamin C and
government subsidies for supplementation, and including regular provision to institutionalized individuals (e.g., elderly
and school children).